Search research articles
Contact Us
Filters
Showing results (11-20 of 318) with videos related to
Page
of 32
Sort By:
Trends in Pharmacological Sciences
|
February 1, 2005
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
Paul T Francis, Agneta Nordberg, Steven E Arnold
Progress in Brain Research
|
December 8, 2004
Neurodevelopment, neuroplasticity, and new genes for schizophrenia
Steven E Arnold, Konrad Talbot, Chang-Gyu Hahn
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?
Sarah B Mathews, Steven E Arnold, C Neill Epperson
JAMA Neurology
|
March 28, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Eric L Ross, Marc S Weinberg, Steven E Arnold
Proteomes
|
September 12, 2018
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
Becky C Carlyle, Bianca A Trombetta, Steven E Arnold
Current Psychiatry Reports
|
December 24, 2015
Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning
Aaron M Koenig, Steven E Arnold, Joel E Streim
JAMA Neurology
|
October 3, 2022
Effectiveness-Essential for Cost-effectiveness-Reply
Eric L Ross, Marc S Weinberg, Steven E Arnold
Frontiers in Aging Neuroscience
|
December 31, 2013
Recognition memory in amnestic-mild cognitive impairment: insights from event-related potentials
David A Wolk, Katharine Manning, Daria Kliot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Chao-Yi Wu, Liu Chen, Steven E Arnold, et al.
Neuroepidemiology
|
December 15, 2005
Odor identification and decline in different cognitive domains in old age
Robert S Wilson, Steven E Arnold, Yuxiao Tang, et al.
Page
of 32
Search research articles
Search
Showing results (11-20 of 318) with videos related to
Sort By:
Page
of 32
Trends in Pharmacological Sciences
|
February 1, 2005
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
Paul T Francis, Agneta Nordberg, Steven E Arnold
Progress in Brain Research
|
December 8, 2004
Neurodevelopment, neuroplasticity, and new genes for schizophrenia
Steven E Arnold, Konrad Talbot, Chang-Gyu Hahn
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?
Sarah B Mathews, Steven E Arnold, C Neill Epperson
JAMA Neurology
|
March 28, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Eric L Ross, Marc S Weinberg, Steven E Arnold
Proteomes
|
September 12, 2018
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
Becky C Carlyle, Bianca A Trombetta, Steven E Arnold
Current Psychiatry Reports
|
December 24, 2015
Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning
Aaron M Koenig, Steven E Arnold, Joel E Streim
JAMA Neurology
|
October 3, 2022
Effectiveness-Essential for Cost-effectiveness-Reply
Eric L Ross, Marc S Weinberg, Steven E Arnold
Frontiers in Aging Neuroscience
|
December 31, 2013
Recognition memory in amnestic-mild cognitive impairment: insights from event-related potentials
David A Wolk, Katharine Manning, Daria Kliot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Chao-Yi Wu, Liu Chen, Steven E Arnold, et al.
Neuroepidemiology
|
December 15, 2005
Odor identification and decline in different cognitive domains in old age
Robert S Wilson, Steven E Arnold, Yuxiao Tang, et al.
Page
of 32